Table 1.
Cancer survival data estimates from Mozambique.
| Population-Based Survival Estimates | |||
|---|---|---|---|
| Author, Year | Cancer | Sample Characteristics | Survival |
| Joko-Fru, 2020 [26] |
Breast | Patients diagnosed in 2015 with breast cancer, randomly selected from the Maputo population-based cancer registry (N = 42 a) | 1-year: overall survival: 75.8%; ASRS: 73.2% (95% CI: 38.0–90.5) |
| Sengayi-Muchengeti, 2020 [27] |
Cervical | Patients diagnosed in 2015 with cervical cancer, selected from the Maputo population-based cancer registry (N = 112) | 1-year: overall survival: 66.2% (95% CI 54.2–75.7); relative survival: 58.7% (95% CI 47.1–68.6) 3-year: overall survival: 55.2% (95% CI 31.6–73.6); relative survival: 54.8% (95% CI 40.2–67.2) |
| Gullickson, 2021 [25] |
Colorectal | Patients diagnosed in 2014–2015 with colorectal cancer, randomly selected from the Maputo population-based cancer registry (N = 23 b) | 1-year c: overall survival: 67.6%; ASRS: 82.7% (95% CI 67.0–91.4) |
| Hospital-Based Survival Estimates | |||
| Author, Year | Cancer | Sample Characteristics | Survival |
| Come, 2018 [29] |
Esophageal | Patients admitted to the MCH, diagnosed between January 2012 and December 2016 (N = 350) | Median survival time: 3.5 months for all patients; 8.7 months for patients treated with curative intent (surgery alone or with neoadjuvant chemotherapy) |
| Brandão, 2021 [28] |
Breast | Patients with a pathological diagnosis treated in the oncological unit of the MCH, diagnosed between January 2015 and February 2016 (N = 98) | 3-year overall survival: 44.8% (95% CI: 34.2–54.8) for cancer stage 0-IV and 48.0% (95% CI: 35.9–59.1) for cancer stage 0-III |
| Patients with a pathological diagnosis treated in the oncological unit of the MCH, diagnosed between March 2016 and August 2017 (N = 107) | 3-year overall survival: 62.6% (95% CI: 51.8–71.6) for cancer stage 0-IV and 73.0% (95% CI: 61.3–81.6) for cancer stage 0-III | ||
ASRS, Age-standardized relative survival (International Cancer Survival Standard); CI, confidence interval; MCH, Maputo Central Hospital. a Corresponding to approximately 64% of all breast cancer cases identified by the Maputo population-based cancer registry for the period considered. b Corresponding to approximately 64% of all colorectal cancer cases identified by the Maputo population-based cancer registry for the period considered. c The results presented for the 1- and the 3-year overall survival were the same.